Last reviewed · How we verify
NCT04930484
Validity and Reliability of the Turkish Version of Performance Measure for Activities of Daily Living-8
trial in Congestive Heart Failure in 68 participants. Completed in 3 August 2021.
3 August 2021
Quick facts
| Lead sponsor | Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 68 |
| Start date | 3 February 2021 |
| Primary completion | 3 August 2021 |
| Estimated completion | 3 August 2021 |
| Sites | 2 locations across Turkey (Türkiye) |
Conditions studied
- Congestive Heart Failure — all drugs for Congestive Heart Failure →
Sponsor
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital
Who can join
Adults 20 to 75, any sex, with Congestive Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic heart failure (CHF) is characterized by limited exercise performance, which is mainly determined by disease-specific factors, such as diminished cardiac output, abnormal ventilatory response, and low perfusion in skeletal muscles, which lead to skeletal muscle dysfunction.1 Exercise intolerance and symptoms may lead to activity restriction and further functional deterioration with the progression of CHF. There is some evidence that disease-specific self-report measures more quantify clinically relevant domains than measures of general health status and are generally more sensitive to clinical change. aim of the study is to investigate the validity and reliability of the PMADL-8 questionnaire in the Turkish population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04930484
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Congestive Heart Failure
Currently open trials in the same condition.
- NCT07008365 — The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure · Phase 3 · recruiting
- NCT06526884 — Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC) · NA · active not recruiting
- NCT06495892 — PVP-Guided Decongestive Therapy in HF 2 · Phase 4 · recruiting
- NCT06374277 — Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence · NA · recruiting
- NCT05971225 — Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe) · NA · recruiting
Other Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital trials
Trials by the same sponsor.
- NCT05242406 — Effect of EMST Systemic Inflammation and Oxidative Stress in Patients With Moderate OSAS · NA · completed
- NCT04454242 — High and Low Intensity Expiratory Muscle Strength Training in Patients With Obstructive Sleep Apnea Syndrome · NA · completed
- NCT04451993 — Physical Activity Level in Patients With OSAS During Covid-19 Pandemic · completed
- NCT04201236 — Oropharyngeal Exercises and Inspiratory Muscle Training in Obstructive Sleep Apnea · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04930484 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital
- Last refreshed: 22 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04930484.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing